Colorectal Cancer Diagnostics Market
Medical Device

Colorectal Cancer Diagnostics Market Scope 2028 – Navigating the Competitive World

Mayur SComment(0)

Colorectal cancer diagnostics refers to the tools, kits and test performed on an individual to diagnose colorectal cancer in an individual. This involves series of non-invasive and invasive test to confirm the cancer and its stage based on that treatment will be provided to the patient.

Medtronic Plc and Boston Scientific Corporation – Notable Market Players in Colorectal Cancer Diagnostics Market

Key driving factors include the factors driving the colorectal cancer diagnostics market growth are increasing prevalence of colorectal cancer and launches of new products. However, the low accuracy of screening based on fecal immunochemical tests (FITs)hinders the colorectal cancer diagnostics market growth. 

The colorectal cancer diagnostics market is majorly comprised of top players involving Medtronic Plc, Illumina Inc, Clinical Genomics Technologies Pty Ltd, EDP Biotech Corp, Epigenomics AG F. Hoffmann-La Roche Ltd, Quest Diagnostics Inc, Novigenix SA, Siemens Healthineers AG, Bruker Corp, and Eiken Chemical Co., Ltd. among others.

The companies listed above are implementing various strategies such as product launches, acquisitions, mergers, and partnerships, which have resulted in the company’s growth and, in turn, have brought about various changes in the worldwide market. Additionally, the companies have adopted several organic strategies for accelerating their growth and improving their market position.

Below is the list of the growth strategies done by the players operating in the colorectal cancer diagnostics market:       

Year

News

March 2023

Sengkang General Hospital collaborate with Medtronic promote AI-assisted colonoscopies.
The two organizations have signed a memorandum of understanding to promote AI-assisted colonoscopy
for colorectal cancer screening.

August 2021

Illumina Acquired GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test.
GRAIL’s Galleri blood test detects 50 different cancers before they are symptomatic. Illumina’s acquisition of
GRAIL will accelerate access and adoption of this life-saving test worldwide.

January 2020

Illumina, Roche Launched NGS-Based Cancer Diagnostics Partnership. Illumina and Roche have
signed a 15-year, non-exclusive collaboration agreement designed to realize next-generation
sequencing’s potential to transform cancer risk prediction, detection, diagnosis, treatment, and monitoring.

April 2020

Clinical Genomics Expands Strategic Relationship with Quest Diagnostics for Innovative First-Line Colorectal Cancer Screening Blood Test.
The alliance also expands the company’s commercialization rights for hte Trident Program and COLVERA for CRC monitoring outside the US,
Mexico, UK, and India.

 

Mayur S
https://www.theinsightpartners.com/

Related Articles

Orthopedic Braces and Supports Market
Medical Device

Orthopedic Braces and Supports Market Is Expected To Reach US$ 5,429.3 Million by 2025

The Insight Partners

Rise in The Geriatric Population Are Likely To Accelerate The Growth Of Orthopedic Braces and Supports Market from 2018 to 2025. The global orthopedic braces and supports market is expected to reach US$ 5,429.3 Mn in 2025 from US$ 3,631.2 Mn in 2017. The orthopedic braces and supports market is estimated to grow with a […]

Insulin Delivery Devices Market
Medical Device

The Growth Of Insulin Delivery Devices Market Accelerate Due to Rapid Growth In The Geriatric Population From 2018 To 2025

The Insight Partners

In the recent years, insulin delivery devices market has progressed significantly. The global insulin delivery devices market is anticipated to grow from US$ 11,869.0 Mn in 2017 to US$ 22,830.0 by 2025 at a CAGR of 8.7%. The rising prevalence of diabetes and rapid growth in the geriatric population are the major factors anticipated to […]

Orthodontic Services Market
Medical Device

Orthodontic Services Market is expected to grow at a CAGR of 11.5% from 2021 to 2028.

The Insight Partners

Orthodontics is the part of dentistry that deals with the diagnosis, positioning, and correction of misaligned or misaligned teeth. According to the American Association of Orthodontics, nearly 50% of the developed world’s population has severe deformities to benefit from orthodontic treatment. For a larger population, orthodontic services encompass so much more than is realized because […]

Leave a Reply

Your email address will not be published.